Event - Dubai Announces Eid Al Etihad 2026 Celebrations from November 2… Transport - Palm Jumeirah VIP Parking Introduces Dh50 Hourly Fee, With Char… Weather - Fair to Partly Cloudy Skies on November 21 as Dubai Temperature…

Send an Inquiry

Fill in the details below and our team will get back to you.

Technology 1 min read 109 views

Medad Technology Leads UAE's Intellectual Property Landscape with 331 Patents

Medad Technology, a subsidiary of Medad Holding and a leading UAE-based HealthTech company, proudly announces a series of groundbreaking milestones that highlight its commitment to revolutionizing the pharmaceutical industry. In 2022, the company invested $150 million in R&D, product development, and manufacturing, paving the way for new advances in Consumer HealthTech, Pharmaceutical HealthTech, and Power Management. This investment has culminated in an impressive portfolio of 331 patents and four proprietary chips, positioning Medad Technology at the forefront of the UAE's thriving intellectual property landscape.

In 2022, Medad Technology accounted for 39% of all patents originating from the UAE at the World Intellectual Property Organization (WIPO), trailing only Khalifa University and Abu Dhabi Oil Company. This achievement underscores Medad Technology's competitive edge in research and development, contributing to the UAE's global standing as the 51st nation in innovation.

Medad Technology has since made significant breakthroughs, including the creation of an ultrasonic delivery system that overcomes the limitations of traditional inhalation devices. By developing advanced proprietary electronics and algorithms, Medad has streamlined power management, enhanced functionality, and operational precision, optimizing aerosol delivery. The innovative chipset, compared to existing off-the-shelf components, has the potential to advance power management beyond inhalation, with multiple applications within the semiconductor industry.

"At Medad Technology, we are dedicated to pushing the boundaries of public health innovation with novel therapeutic solutions. Our achievements in patent acquisition and the development of proprietary technologies demonstrate an unwavering commitment to improving patient outcomes. Innovation is central to the UAE's economic growth, and Medad remains committed to contributing to this vision by establishing a strong presence in R&D, design, engineering, product development, and manufacturing," said Mohammed Alshaiba Almazrouei, President of Medad Technology.

In a recent clinical study, Medad Technology's cutting-edge ultrasonic delivery system, featuring proprietary chips and algorithms, demonstrated unparalleled efficiency in drug delivery by controlling aerosol particle size. The technology enables direct delivery to the deepest regions of the lungs through inhalation, bypassing the user's metabolism and facilitating direct bloodstream absorption.

The success of Medad's technology marks a significant leap forward in improving drug delivery efficiency, thus enhancing the prevention and treatment of chronic illnesses and enabling the inhalation of medications previously limited to oral administration in pill form. This breakthrough has the potential to transform the pharmaceutical field by lowering costs through dose reduction and minimizing drug wastage while mitigating the side effects of traditional oral medications.

Medad Technology is primarily focusing on evaluating its technology as a nicotine replacement therapy to aid smoking cessation. With tobacco smoking being the leading cause of preventable death, accounting for over 8 million deaths globally per year according to the WHO, the company's innovative approach offers a promising solution. Unlike traditional nicotine replacement therapy products, efficiently delivering nicotine through inhalation provides rapid relief of cravings while maintaining the habitual aspect, ultimately increasing the success rate of quitting smoking. The use of ultrasound eliminates the chemicals that cause smoking-related diseases, such as formaldehyde and acrolein, reducing potential harm to the user.

Additionally, Medad Technology is developing novel drug delivery methods to treat diseases such as pulmonary hypertension, a condition becoming more prevalent as the world's population ages. The company's inhalation-based treatment is designed to reduce side effects commonly associated with existing pill-based medications, providing a more effective and patient-friendly treatment option.

Medad Technology's groundbreaking advancements mark a significant leap forward in improving drug delivery efficiency, opening doors for developing novel, cost-effective, and patient-centric treatment options. As the company continues to innovate, Medad Technology is committed to shaping the future of the HealthTech industry by integrating AI and large language models (LLMs) into their solutions. With a forward-looking vision, the company strives to establish the UAE as a vibrant hub of engineering and manufacturing excellence. Central to this ambition is their state-of-the-art facility in Abu Dhabi, where research and design converge with rapid prototyping, PCB population, and production processes, affirming their dedication to excellence and the development of an eminent UAE-made product portfolio.

<meta name="description" content="Medad Technology leads UAE's Intellectual Property landscape with 331 patentshighlighting its competitive edge in R&D and innovations in public health.">

Related News

More on Technology

View all

Comments (0)

Join the conversation

No comments yet. Be the first to share your thoughts!

More News

See all
Business

Nabat and Indonesia Partner at COP31 to Advance AI-Powered Mangrove Restoration

Abu Dhabi-based Nabat, a nature technology company of the Advanced Technology Research Council (ATRC), has signed a collaboration agreement with Indonesia’s Coordinating Ministry for Food Affairs (CMFA) at COP31 to advance AI-powered mangrove ecosystem management in Demak, Central Java. The...

Nov 21, 2026 · 2 min
Art and Culture

Sharjah Opens 55th Eid Al Etihad Celebrations at Kshisha Park

The Sharjah Eid Al Etihad Celebrations Committee has launched the emirate’s main programme for the UAE’s 55th Eid Al Etihad, with an opening ceremony at Kshisha Park on 19 November. Running until 3 December, the celebrations bring together residents and visitors through cultural,...

Nov 21, 2026 · 3 min
Technology

Dubai State of AI Report 2026 Highlights Shift from Pilot Projects to Citywide AI Integration

Digital Dubai, in collaboration with the Dubai Future Foundation, has launched the second edition of the Dubai State of AI Report 2026 under the theme “Scaling with Trust”. The report was unveiled during the AI Retreat, held as part of Dubai Future Week 2026, which runs from 18 to 21...

Nov 21, 2026 · 3 min
Education

Al Tamimi & Company Founder Essam Al Tamimi to Address Abu Dhabi University Entrepreneurship Students

Essam Al Tamimi, Founder and Chairman of Al Tamimi & Company, is scheduled to deliver a guest lecture to students enrolled in Abu Dhabi University’s Innovation and Entrepreneurship course on 24 November 2026. The session will draw on Al Tamimi’s experience of establishing and...

Nov 21, 2026 · 1 min
Trusted by

Our Associates

Brands and organisations that work with Day of Dubai.